Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company appears highly valued given the size of its balance sheet.

● The company is not the most generous with respect to shareholders' compensation.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.